Рет қаралды 476,727
Become a member of this channel to enjoy the following benefits: / @wangzhian
On July 13th, Rao Yi posted on his public WeChat account that the final verdict was reached in the defamation case filed against him by Geng Meiyu, and Geng Meiyu lost the lawsuit. This prolonged legal battle between the two scientists has finally come to an end. However, Geng Meiyu's globally first drug for treating Alzheimer's disease, named "971," is still going through regulatory hurdles for market approval and has also been included in China's medical insurance catalog.
Who is Geng Meiyu? Why did she sue Rao Yi? Does "971" really have therapeutic effects? What does its market approval signify?